Gerald Boudreaux, D-Lafayette, would require the Louisiana Department of Health to provide coverage for FDA-approved weight loss medications, including GLP-1s that are medically necessary. GLP-1 medication, both the shots and pills, for the states Medicaid patients is currently covered for those with a certain level of obesity and "co-occurring conditions" (such as Type 2 diabetes, sleep apnea and congestive heart failure)
Consistently, cells expressing WT or S1025D exhibited more continuous and organized Golgi ribbon structures, whereas S1025A expression resulted in fragmented and disorganized Golgi morphology (Figure 4F, G)
By mimicking the GLP-1 hormone, Ozempic helps to improve insulin production and reduce blood sugar spikes
"FDA links child deaths to chelation therapy"
If products become healthier, everyone benefits
Exploring Specific Therapeutic Niches Given its broad effects, future research could focus on identifying specific medical conditions where BPC-157 offers a unique advantage or addresses unmet medical needs